BIONIK Laboratories Corp has entered a multi-year agreement with Kindred Hospital Rehabilitation Services to provide multiple units of the Company’s InMotion Arm robotic system to help patients regain mobility after stroke or neurological impairment.

As part of the agreement, Kindred will begin installing InMotion robots in its existing inpatient rehabilitation hospitals and similar facilities across the US this month with a second phase to include installation in new Kindred inpatient rehabilitation hospitals and similar facilities within the next 4 years, according to a news release.

“We are thrilled to enter into this agreement with BIONIK and to bring their world-class rehabilitation technology to patients across the country. The implementation of BIONIK’s InMotion Arm system within our facilities will enable our facilities to provide an enhanced level of patient treatment and therapy for survivors of stroke and other neurological impairments,” says Russ Bailey, COO/senior vice president of operations at Kindred, in the release.

The agreement with Kindred represents a successful continued penetration into a critical market for BIONIK, the company states in the release. 

“Kindred Hospital Rehabilitation Services is a recognized healthcare leader in the United States, so we are extremely pleased to see such a first-class, growing institution adopting our InMotion systems to provide innovative treatments at its facilities,” comments Dr Eric Dusseux, chief executive officer and director of BIONIK.

“This is a tremendous opportunity for us to demonstrate the impact of our technology on a broader scale, and to further penetrate the US healthcare and rehabilitation market while generating immediate revenue for BIONIK. We are excited about entering this new relationship and to bring our industry-leading therapeutic robotic technologies to Kindred facilities across the country.”

InMotion Arm therapy is designed to guide the patient through specific tasks, aiming to improve motor control of the arm by increasing strength, range of motion and coordination, and assists with the provision of efficient, effective, intensive sensorimotor therapy.

[Source(s): BIONIK Laboratories Corp, PR Newswire]